Author

J. Wulfkuhle

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

C. J. Essenburg· 1 shared C. Lehman· 1 shared C. R. Graveel· 1 shared D. Gioeli· 1 shared E. A. Tovar· 1 shared E. F. Petricoin· 1 shared E. Petricoin· 1 shared E. Wolfrum· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C. J. Essenburg

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

p53 modulates kinase inhibitor resistance and lineage plasticity in NF1-related MPNSTs

J. L. Grit, L. E. McGee, E. A. Tovar, C. J. Essenburg, E. Wolfrum, I. Beddows, K. Williams, R. Sheridan, J. Schipper, M. Adams, M. Arumugam, T. Vander Woude, S. Gurunathan, J. M. Field, J. Wulfkuhle, , M. Steensma

This study shows p53 loss in NF1-related MPNSTs leads to MET instability, kinome reprogramming, and therapy resistance through altered signaling and lineage plasticity.

bioRxiv · Jan 18, 2023Cancer Biology

The potentiative cytotoxic effect of IGF1R and EGFR inhibition on the Head and Neck Cancer Proteome

S. Hall, C. Lehman, J. Wulfkuhle, E. Petricoin, S. Bekiranov, S. Dolatshahi, M. Jameson, D. Gioeli

This study investigates the combined effect of IGF1R and EGFR inhibitors on HNSCC proteome, showing enhanced inhibition of receptor tyrosine kinase signaling through pathway analysis.

bioRxiv · Oct 13, 2022 · PreprintCancer Biology